Hans-Dieter Höltje - Publications

Affiliations: 
Pharmacy Heinrich Heine University Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany 
Area:
Pharmaceutical Chemistry
Website:
http://www.duw-berlin.de/startseite/verknuepfungselemente/lehrende/lehrende-g-l/hoeltje.html

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Hillmann P, Ko GY, Spinrath A, Raulf A, Von Kügelgen I, Wolff SC, Nicholas RA, Kostenis E, Höltje HD, Müller CE. Key determinants of nucleotide-activated G protein-coupled P2Y2 receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling Journal of Medicinal Chemistry. 52: 2762-2775. PMID 19419204 DOI: 10.1021/Jm801442P  0.369
2008 Thielmann Y, Mohrlüder J, Koenig BW, Stangler T, Hartmann R, Becker K, Höltje HD, Willbold D. An indole-binding site is a major determinant of the ligand specificity of the GABA type A receptor-associated protein GABARAP Chembiochem. 9: 1767-1775. PMID 18567048 DOI: 10.1002/cbic.200800117  0.326
2007 Schlegel B, Laggner C, Meier R, Langer T, Schnell D, Seifert R, Stark H, Höltje HD, Sippl W. Generation of a homology model of the human histamine H3 receptor for ligand docking and pharmacophore-based screening Journal of Computer-Aided Molecular Design. 21: 437-453. PMID 17668276 DOI: 10.1007/S10822-007-9127-X  0.556
2005 Schlegel B, Sippl W, Höltje HD. Molecular dynamics simulations of bovine rhodopsin: Influence of protonation states and different membrane-mimicking environments Journal of Molecular Modeling. 12: 49-64. PMID 16247601 DOI: 10.1007/S00894-005-0004-Z  0.458
2005 Schlegel B, Stark H, Sippl W, Höltje HD. Model of a specific human histamine H3 receptor (hH 3R) binding pocket suitable for virtual drug design Inflammation Research. 54: S50-S51. PMID 15928832 DOI: 10.1007/S00011-004-0423-9  0.546
2005 Jöhren K, Höltje HD. Different environments for a realistic simulation of GPCRs-application to the M2 muscarinic receptor Archiv Der Pharmazie. 338: 260-267. PMID 15924369 DOI: 10.1002/ardp.200400992  0.346
2005 Terzioglu N, Höltje HD. Receptor-based 3D QSAR analysis of serotonin 5-HT1D receptor agonists Collection of Czechoslovak Chemical Communications. 70: 1482-1492. DOI: 10.1135/cccc20051482  0.318
2003 Bröer BM, Gurrath M, Höltje HD. Molecular modelling studies on the ORL1-receptor and ORL1-agonists Journal of Computer-Aided Molecular Design. 17: 739-754. PMID 15072434 DOI: 10.1023/B:JCAM.0000017491.97244.69  0.463
2003 Hammer S, Spika I, Sippl W, Jessen G, Kleuser B, Höltje HD, Schäfer-Korting M. Glucocorticoid receptor interactions with glucocorticoids: Evaluation by molecular modeling and functional analysis of glucocorticoid receptor mutants Steroids. 68: 329-339. PMID 12787894 DOI: 10.1016/S0039-128X(03)00030-8  0.565
2002 Jöhren K, Höltje HD. A model of the human M2 muscarinic acetylcholine receptor Journal of Computer-Aided Molecular Design. 16: 795-801. PMID 12825791 DOI: 10.1023/A:1023880611709  0.391
2002 Stoll F, Liesener S, Hohlfeld T, Schrör K, Fuchs PL, Höltje HD. Pharmacophore definition and three-dimensional quantitative structure-activity relationship study on structurally diverse prostacyclin receptor agonists. Molecular Pharmacology. 62: 1103-11. PMID 12391273 DOI: 10.1124/mol.62.5.1103  0.379
2002 Iadanza M, Höltje M, Ronsisvalle G, Höltje HD. κ-opioid receptor model in a phospholipid bilayer: Molecular dynamics simulation Journal of Medicinal Chemistry. 45: 4838-4846. PMID 12383009 DOI: 10.1021/jm0209127  0.407
2000 Cinone N, Höltje HD, Carotti A. Development of a unique 3D interaction model of endogenous and synthetic peripheral benzodiazepine receptor ligands Journal of Computer-Aided Molecular Design. 14: 753-768. PMID 11131968 DOI: 10.1023/A:1008168127539  0.4
2000 Sippl W, Höltje HD. Structure-based 3D-QSAR - Merging the accuracy of structure-based alignments with the computational efficiency of ligand-based methods Journal of Molecular Structure: Theochem. 503: 31-50. DOI: 10.1016/S0166-1280(99)00361-9  0.513
1999 Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Höltje HD, Schäfer-Korting M. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin Pharmaceutical Research. 16: 1386-1391. PMID 10496654 DOI: 10.1023/A:1018946924585  0.392
1998 Schleifer KJ, Tot E, Höltje HD. Pharmacophore and pseudoreceptor modelling of class Ib antiarrhythmic and local anaesthetic lidocaine analogues Pharmazie. 53: 596-602. PMID 9770207  0.313
1998 Sippl W, Stark H, Höltje HD. Development of a binding site model for histamine H3-receptor agonists Pharmazie. 53: 433-437. PMID 9699219  0.506
1998 Sippl W, Stark H, Höltje HD. Development of a binding site model for histamine H3-receptor agonists Pharmazie. 53: 433-437. PMID 9699219  0.597
1997 Höltje HD, Sippl W. Molecular modelling studies on histamine H2- and H3-receptor agonists Pharmacochemistry Library. 28: 137-148. DOI: 10.1016/S0165-7208(97)80060-8  0.569
1997 Höltje HD, Sippl W. Molecular modelling studies on histamine H2- and H3-receptor agonists Pharmacochemistry Library. 28: 137-148. DOI: 10.1016/S0165-7208(97)80060-8  0.423
1995 Höltje HD, Jendretzki UK. Construction of a detailed serotoninergic 5-HT2a receptor model. Archiv Der Pharmazie. 328: 577-84. PMID 7492262  0.35
1995 Sippl W, Stark H, Holtje HD. Computer-assisted analysis of histamine H2- and H3-receptor agonists Quantitative Structure-Activity Relationships. 14: 121-125. DOI: 10.1002/Qsar.19950140203  0.59
1994 Sippl W, Höltje HD. P81 sterical and electronical properties of histamine H2-agonists European Journal of Pharmaceutical Sciences. 2: 139. DOI: 10.1016/0928-0987(94)90254-2  0.435
1993 Höltje HD, Dall N. A molecular modelling study on the hormone binding site of the estrogen receptor. Die Pharmazie. 48: 243-9. PMID 8391709  0.351
1993 Höltje HD. [Molecular modelling studies on hormone binding regulation by estrogen receptors]. Archiv Der Pharmazie. 326: 765-8. PMID 8267512  0.346
1990 Höltje HD, Batzenschlager A. Conformational analyses on histamine H2-receptor antagonists. Journal of Computer-Aided Molecular Design. 4: 391-402. PMID 1982629  0.421
1989 Höltje HD. Molecular modelling of the interaction of dihydropyridine drugs with their receptors. Progress in Clinical and Biological Research. 291: 237-41. PMID 2542977  0.349
1987 Höltje HD, Adler P. [Theoretical research on the interaction between drugs and receptor models. VIII. An interaction model for the binding of sulfonamides on human serum albumin]. Archiv Der Pharmazie. 320: 234-40. PMID 3579525  0.33
1986 Höltje HD. [Molecular modeling of the structure of barbiturate receptors]. Archiv Der Pharmazie. 319: 570-2. PMID 3017268 DOI: 10.1002/ARDP.19863190617  0.38
1986 Tintelnot M, Höltje HD. Conformational studies on histamine H2-receptor antagonists: deduction of a simple structure-activity relationship Journal of Molecular Graphics. 4: 7-11. DOI: 10.1016/0263-7855(86)80087-X  0.409
1985 Höltje HD, Baranowski P, Spengler JP, Schunack W. [A binding-site model for H2-antagonists of the 4-pyrimidinone type]. Archiv Der Pharmazie. 318: 542-8. PMID 2862855  0.334
1983 Höltje HD, Baranowski P. [Theoretical investigations of interactions between drugs and models of receptor sites, 3: induced fit interactions of verapamil derivatives]. Archiv Der Pharmazie. 316: 154-60. PMID 6847345  0.305
1979 Höltje HD. [Theoretical studies on drug-receptor model complexes]. Pharmaceutica Acta Helvetiae. 54: 125-34. PMID 386361  0.301
1978 Höltje HD. [Theoretical studies on interactions between pharmacon models and ionic receptor binding sites (author's transl)]. Archiv Der Pharmazie. 311: 2-11. PMID 626563  0.348
1975 Kier LB, Höltje HD. A stochastic model of the remote recognition of preferred conformation in a drug-receptor interaction. Journal of Theoretical Biology. 49: 401-16. PMID 1121187 DOI: 10.1016/0022-5193(75)90181-2  0.341
Show low-probability matches.